Regulatory Affairs Updates
Discover the latest news in Regulatory Affairs
MDCG 2024-12 released
- Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager
On October 7th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance and templates for the assessment of Corrective and Preventive Action (CAPA) plans, intended for conformity assessment bodies, notified bodies, designating authorities, and Joint Assessment Teams involved in the implementation of Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR). It includes detailed sections on corrections, root cause analysis, corrective and preventive actions, and actions for verification of effectiveness. The document also provides templates in Annex I and Annex II to facilitate a consistent and efficient CAPA review process.
What does it mean to you?
MDCG 2024-12 does not directly target manufacturers of IVDs and medical devices. Nonetheless, corrective actions to be taken by notified bodies may have an impact on existing certificates for such manufacturers.
Get in touch with our experts
Did you find this article interesting? Thanks for sharing it with your network:
Here you find all news related to Regulatory Affairs